2018 annual financial data

Voyager Therapeutics, Inc. 2018 Operating margin

Voyager Therapeutics, Inc. 2018 operating margin with verified reported values.

Direct answer

Operating margin was -1,195.63%.

Operating income was -91,095,000 USD and net income was -88,288,000 USD.
Operating cash flow was -15,887,000 USD.

Get free Voyager Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,619,000 USD
Operating income
-91,095,000 USD
Net income
-88,288,000 USD
Operating cash flow
-15,887,000 USD